Clinical Trial: Evaluation of the Performance and Safety of Hyalo Gyn(R) Gel Compared to Placebo in Postmenopausal Breast Cancer Survivors

U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06922136) titled 'Evaluation of the Performance and Safety of Hyalo Gyn(R) Gel Compared to Placebo in Postmenopausal Breast Cancer Survivors' on March 17.

Brief Summary: Eligible patients will be randomized to treatment with Hyalo Gyn(R) gel or placebo, at the dose regimen of 1 application deeply in the vagina every 3 days (i.e. an application is followed by 2 days without application), up to a total of 12 consecutive weeks.

After 12 weeks (i.e. at Visit 3), the following rules will apply for the second 12- week phase of the study:

* In case of resolution of the symptom (the dryness single score is equal to zero), the patient will suspend treatmen...